Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: JVN025
MIFTS: 23

Juvenile Primary Osteoporosis

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases
Tissues Related diseases Publications Drugs
Sources

Aliases & Classifications for Juvenile Primary Osteoporosis

About this section

MalaCards integrated aliases for Juvenile Primary Osteoporosis:

Name: Juvenile Primary Osteoporosis 25 72
Childhood-Onset Primary Osteoporosis 25
Idiopathic Juvenile Osteoporosis 25
Juvenile Osteoporosis 72

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Fetal diseases
Anatomical: Bone diseases
See all MalaCards categories (disease lists)


External Ids:

UMLS 72 C0264080 C3711559
Sources

Summaries for Juvenile Primary Osteoporosis

About this section
Genetics Home Reference : 25 Juvenile primary osteoporosis is a skeletal disorder characterized by thinning of the bones (osteoporosis) that begins in childhood. Osteoporosis is caused by a shortage of calcium and other minerals in bones (decreased bone mineral density), which makes the bones brittle and prone to fracture. Affected individuals often have multiple fractures in the long bones of the arms and legs, especially in the regions where new bone forms (metaphyses). They also have fractures in the bones that form the spine (vertebrae), which can cause collapse of the affected vertebrae (compressed vertebrae). Multiple fractures can cause bone pain and lead to movement problems.

MalaCards based summary : Juvenile Primary Osteoporosis, also known as childhood-onset primary osteoporosis, is related to osteoporosis, juvenile and osteoporosis. The drugs Alendronate and Calcium carbonate have been mentioned in the context of this disorder. Affiliated tissues include bone, skin and testes.

Sources

Related Diseases for Juvenile Primary Osteoporosis

About this section

Diseases in the Osteoporosis family:

Osteoporosis, Juvenile Juvenile Primary Osteoporosis

Diseases related to Juvenile Primary Osteoporosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 17)
# Related Disease Score Top Affiliating Genes
1 osteoporosis, juvenile 12.6
2 osteoporosis 10.8
3 bone mineral density quantitative trait locus 8 10.8
4 bone mineral density quantitative trait locus 15 10.8
5 bone disease 10.3
6 bone resorption disease 10.3
7 brittle bone disorder 10.2
8 col1a1/2-related osteogenesis imperfecta 10.2
9 back pain 10.1
10 osteogenesis imperfecta, type i 10.1
11 hyperparathyroidism 10.1
12 osteogenesis imperfecta, type iii 9.9
13 lymphoma 9.9
14 scoliosis 9.9
15 secondary hyperparathyroidism 9.9
16 ehlers-danlos syndrome 9.9
17 47,xyy 9.9

Graphical network of the top 20 diseases related to Juvenile Primary Osteoporosis:



Diseases related to Juvenile Primary Osteoporosis
Sources

Symptoms & Phenotypes for Juvenile Primary Osteoporosis

About this section
Sources

Drugs & Therapeutics for Juvenile Primary Osteoporosis

About this section

Drugs for Juvenile Primary Osteoporosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 20)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Alendronate Approved Phase 2 66376-36-1, 121268-17-5 2088
2
Calcium carbonate Approved, Investigational Phase 2 471-34-1
3
Calcium Approved, Nutraceutical Phase 2 7440-70-2 271
4
Vitamin D3 Approved, Nutraceutical Phase 2 67-97-0 6221 5280795
5
Ergocalciferol Approved, Nutraceutical Phase 2 50-14-6 5280793
6
Vitamin D Approved, Nutraceutical, Vet_approved Phase 2 1406-16-2
7 Calcium, Dietary Phase 2
8 Calcium Supplement Phase 2
9 Bone Density Conservation Agents Phase 2
10 glucocorticoids Phase 2
11 Diphosphonates Phase 2
12 Micronutrients Phase 2
13 Hormones Phase 2
14 Trace Elements Phase 2
15 Vitamins Phase 2
16 Ergocalciferols Phase 2
17 Nutrients Phase 2
18 Vitamin D2 Phase 2
19 Calciferol Phase 2
20
Zoledronic Acid Approved 118072-93-8 68740

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 A Non-Randomized, Open-Label, Prospective, Non-Controlled, 12-Month Clinical Trial to Determine the Effects of Alendronate 35 or 70 mg/Week Depending Upon Body Weight, in Children and Adolescent With IJO Completed NCT00010439 Phase 2 Alendronate
2 Alendronate Versus Placebo for Idiopathic Juvenile Osteoporosis Completed NCT00001720 Phase 2 Alendronate
3 A Randomized, Double-Blind, Placebo-Controlled, Prospective, Cross-Over Phase II Clinical Trial to Determine the Safety and Efficacy of Alendronate (Fosamax) in Juvenile Osteoporosis (IND#60,017) Completed NCT00259857 Phase 2 Alendronate
4 Molecular Genetic Study of Suspected Cases of Osteogenesis Imperfecta Attending Assiut University Children Hospital Unknown status NCT03169192 Zoledronic Acid
5 The Influence of Bisphosphonates in the Oral Cavity in Children Completed NCT00402064
6 Phase II Study of Alendronate Sodium in Juvenile Osteoporosis (IND# 60,017)-Post Study Evaluation of Participants From Phase IIa and Phase IIb Clinical Study. Completed NCT00920075 Alendronate (Fosamax)

Search NIH Clinical Center for Juvenile Primary Osteoporosis

Sources

Genetic Tests for Juvenile Primary Osteoporosis

About this section
Sources

Anatomical Context for Juvenile Primary Osteoporosis

About this section

MalaCards organs/tissues related to Juvenile Primary Osteoporosis:

41
Bone, Skin, Testes
Sources

Publications for Juvenile Primary Osteoporosis

About this section

Articles related to Juvenile Primary Osteoporosis:

(show top 50) (show all 127)
# Title Authors PMID Year
1
Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece. 38
30499050 2019
2
Siglec-15-targeting therapy increases bone mass in rats without impairing skeletal growth. 38
30076992 2018
3
Novel PLS3 variants in X-linked osteoporosis: Exploring bone material properties. 38
29736964 2018
4
Severe bone loss and multiple fractures in SCN8A-related epileptic encephalopathy. 38
28676440 2017
5
Primary osteoporosis in children. 38
28866630 2017
6
A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl. 38
27379824 2017
7
Atypical femur fracture in an adolescent boy treated with bisphosphonates for X-linked osteoporosis based on PLS3 mutation. 38
27477003 2016
8
Genetic control of bone mass. 38
26747728 2016
9
Potential blindness in children of patients with hereditary bone disease. 38
26243358 2016
10
Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5. 38
26904320 2016
11
Evidence of altered matrix composition in iliac crest biopsies from patients with idiopathic juvenile osteoporosis. 38
26539896 2016
12
[Osteoporosis - epidemiology and pathogenesis]. 38
28124937 2016
13
Effect of alendronate on the mandible and long bones: an experimental study in vivo. 38
26331769 2015
14
A look behind the scenes: the risk and pathogenesis of primary osteoporosis. 38
25900210 2015
15
Idiopathic Juvenile Osteoporosis: A Case Report. 38
26436063 2015
16
Idiopathic Juvenile Osteoporosis: Clinical Experience from a Single Centre and Screening of LRP5 and LRP6 Genes. 38
25783012 2015
17
Idiopathic juvenile osteoporosis: A case report and review of the literature. 38
25768278 2015
18
Radiographic and MR Imaging Findings of the Spine after Bisphosphonate Treatment, in a Child with Idiopathic Juvenile Osteoporosis. 38
25688321 2015
19
The risk of bisphosphonate-related osteonecrosis of the jaw in children. A case report and literature review. 38
24386765 2013
20
Whole-exome sequencing reveals a heterozygous LRP5 mutation in a 6-year-old boy with vertebral compression fractures and low trabecular bone density. 38
23886840 2013
21
Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients. 38
23549954 2013
22
[Idiopathic juvenile osteoporosis]. 38
23490432 2013
23
Juvenile osteoporosis in a 5-year-old girl. 38
24082756 2013
24
Case history of juvenile osteoporosis associated with LRP5 abnormality. 38
24422159 2013
25
Idiopathic juvenile osteoporosis: a cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography. 38
23418950 2013
26
Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment. 38
22456437 2012
27
Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. 38
21455736 2011
28
Various types of LRP5 mutations in four patients with osteoporosis-pseudoglioma syndrome: identification of a 7.2-kb microdeletion using oligonucleotide tiling microarray. 38
20034086 2010
29
Severe osteoporosis and high level TSH in a child before the diagnosis of acute lymphoblastic leukemia. 38
19636264 2009
30
Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates. 38
18602879 2008
31
[Juvenile osteoporosis]. 38
18329256 2008
32
[One- and two-stage procedure for revision after failure of anterior cruciate ligament reconstruction]. 38
18072036 2007
33
[Bone mineral density in children and adolescents with idiopathic chronic musculoskeletal pain syndromes]. 38
17405294 2006
34
[Back pain and dorsal kyphosis in childhood]. 38
17058388 2006
35
Idiopathic juvenile osteoporosis--an analysis of the muscle-bone relationship. 38
16951909 2006
36
How to manage osteoporosis in children. 38
16301193 2005
37
Bisphosphonate treatment of pediatric bone disease. 38
16361982 2005
38
Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children. 38
15824851 2005
39
[Diagnosis and treatment of juvenile osteoporosis]. 38
15885552 2005
40
Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis. 38
15517381 2005
41
Three children with lower limb fractures and a mineralization defect: a novel bone fragility disorder? 38
15542026 2004
42
[Wnt/LRP5, a new regulation osteoblastic pathway involved in reaching peak bone masses]. 38
15095618 2004
43
Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. 38
12700367 2003
44
Juvenile osteoporosis: recognizing the risk. 38
12795371 2003
45
The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. 38
12110417 2002
46
Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice. 38
12054176 2002
47
Idiopathic juvenile osteoporosis. 38
11973603 2002
48
Use of bisphosphonates in children and adolescents. 38
12199351 2002
49
Osteoporosis in children and adolescent girls: case report of idiopathic juvenile osteoporosis and review of the literature. 38
11496161 2001
50
Clinical evaluation of patients with idiopathic juvenile osteoporosis. 38
11497372 2001
Sources

Variations for Juvenile Primary Osteoporosis

About this section
Sources

Expression for Juvenile Primary Osteoporosis

About this section
Search GEO for disease gene expression data for Juvenile Primary Osteoporosis.
Sources

Pathways for Juvenile Primary Osteoporosis

About this section
Sources

GO Terms for Juvenile Primary Osteoporosis

About this section
Sources

Sources for Juvenile Primary Osteoporosis

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....